Ronald K Potkul, MD
Gynecologic Oncology, Obstetrics & Gynecology
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
888-584-7888
Appointments (New Patients Welcome)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
888-584-7888Services & Specialties
Areas of Specialization
- Gynecologic Oncology
- Obstetrics & Gynecology
Clinical Interests
Conditions Treated
- sentinel lymph node biopsy
- cervical and endometrial cancer surgery
- cervical and endometrial cancers
- Complex Pelvic Surgery
- Vaginal Cancer
- gestational trophoblastic disease
- minimally invasive gynecologic surgery
- ovarian cancer
- ovarian cancer surgery
- Robotic Gynecological Surgery
- gynecologic cancer surgery
- vulvar cancer
- leiomyosarcoma
- paget's disease of vulva
- radical vulvectomy
Locations & Contact
Primary Location
Loyola University Medical Center
2160 S First Ave
Maywood, IL 60153
About
Academic Title
Professor
Leadership Title
Department Chairperson, Obstetrics and Gynecology
Ages Seen
Adults - Over 65
Adults - 18 to 64
Additional Resources
Education & Certifications
Education
Education:
University of Chicago Pritzker School of Medicine
(1981)
Internship:
University of Chicago Medical Center
(1982)
Residency:
University of Chicago Medical Center
(1985)
Fellowship:
Georgetown University Hospital
(1988)
Board Certifications
Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics & Gynecology Subspecialty (1990)
Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics and Gynecology Subspecialty (1990)
Obstetrics and Gynecology, American Board of (1989)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Publications
- Gynecologic Oncology Patients have Urobiomes that are Similar to Women Without Gynecologic Cancer. Nasse, A.; Winder, A.; Noronha, M. F.; Liotta, M. R.; Potkul, R. K.; Mueller, E. R.; Brubaker, L.; Wolfe, A. J.; International urogynecology journal
- Cabozantinib inhibits tumor growth in mice with ovarian cancer. Stiff, P. J.; Kertowidjojo, E.; Potkul, R. K.; Banerjee, S.; Mehrotra, S.; Small, W.; Stack, M. S.; Drakes, M. L.; American journal of cancer research
- Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Ross, D. H.; Gomez, K.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Goldberg, A.; Liotta, M.; Potkul, R.; Winder, A.; Lee, B.; Jackson, J.; Roeske, J. C.; Small, W.; Harkenrider, M. M.; Gynecologic oncology
- Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Stiff, P. J.; Mehrotra, S.; Potkul, R. K.; Banerjee, S.; Walker, C.; Drakes, M. L.; Cancers
- Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer. Buehner, T. M.; Liotta, M.; Potkul, R. K.; Wagner, R. H.; Savir-Baruch, B.; Molecular imaging and biology
- Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management. Small, W.; Kim, Y. S.; Joyce, C.; Surucu, M.; Leshyk, M.; Harkenrider, M. M.; Potkul, R. K.; Liotta, M.; Winder, A.; Altoos, B.; Brachytherapy
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Fukushiro-Lopes, D.; Hegel, A. D.; Russo, A.; Senyuk, V.; Liotta, M.; Beeson, G. C.; Beeson, C. C.; Burdette, J.; Potkul, R. K.; Gentile, S.; Frontiers in pharmacology
- Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity. McAlarnen, L. A.; Ryan, K.; Adams, W.; Gliniewicz, A.; Winder, A. D.; Liotta, M. R.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Gynecologic oncology reports
- Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients? Nieto, K.; Martin, B.; Pham, N.; Palmere, L.; Silva, S. R.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
- Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, M. L.; Mehrotra, S.; Aldulescu, M.; Potkul, R. K.; Liu, Y.; Grisoli, A.; Joyce, C.; O'Brien, T. E.; Stack, M. S.; Stiff, P. J.; Journal of ovarian research
- Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Kharouta, M. Z.; Pham, N.; Nieto, K.; Surucu, M.; Mysz, M. L.; Albuquerque, K.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
- Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program. Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W.; Brachytherapy
- Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S.; NPJ breast cancer
- How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer. Harkenrider, M. M.; Shea, S. M.; Wood, A. M.; Chinsky, B.; Bajaj, A.; Mysz, M.; Yacoub, J. H.; Goldberg, A.; Liotta, M.; Potkul, R.; Surucu, M.; Roeske, J.; Small, W.; Journal of contemporary brachytherapy
- Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman. Bahar, B.; Hu, Z.; Szpaderska, A.; Liotta, M.; Potkul, R. K.; Smith, D.; Erşahin, Ç.; International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
- Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Albuquerque, K.; Giangreco, D.; Morrison, C.; Siddiqui, M.; Sinacore, J.; Potkul, R.; Roeske, J.; International journal of radiation oncology, biology, physics
- Hepatic resection for recurrent metastatic ovarian cancer. Abood, G.; Bowen, M.; Potkul, R.; Aranha, G.; Shoup, M.; American journal of surgery
- FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast. Omeroglu, G.; Ersşahin, C.; Potkul, R. K.; Booth, C. N.; Diagnostic cytopathology
- Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia. Erşahin, C.; Omeroglu, G.; Potkul, R. K.; Salhadar, A.; Gynecologic oncology
- Mesonephric adenocarcinoma of the vagina with a 3-year follow-up. Erşahin, C.; Huang, M.; Potkul, R. K.; Hammadeh, R.; Salhadar, A.; Gynecologic oncology
- Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B.; Gynecologic oncology
- Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Wakabayashi, M. T.; Da Silva, D. M.; Potkul, R. K.; Kast, W. M.; Intervirology
- A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy. Small, L. A.; Da Silva, D. M.; de Visser, K. E.; Velders, M. P.; Fisher, S. G.; Potkul, R. K.; Kast, W. M.; Clinical cancer research : an official journal of the American Association for Cancer Research
- Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes. Contreras, D. N.; Krammer, P. H.; Potkul, R. K.; Bu, P.; Rossi, J. L.; Kaufmann, A. M.; Gissmann, L.; Qiao, L.; Journal of immunotherapy (Hagerstown, Md. : 1997)
- Sonographic assessment of an inaccessible chemotherapy infusion port. Kalbhen, C. L.; Salomon, C. G.; Contreras, D. N.; Smith, D. M.; Potkul, R. K.; AJR. American journal of roentgenology
- PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. Nieland, J. D.; Loviscek, K.; Kono, K.; Albain, K. S.; McCall, A. R.; Potkul, R. K.; Fisher, S. G.; Velders, M. P.; Petersson, M.; Kiessling, R.; Kast, W. M.; Journal of immunotherapy (Hagerstown, Md. : 1997)
- A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Irvin, W. P.; Price, F. V.; Bailey, H.; Gelder, M.; Rosenbluth, R.; Durivage, H. J.; Potkul, R. K.; Cancer
- Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice. Michelin, D.; Gissmann, L.; Street, D.; Potkul, R. K.; Fisher, S.; Kaufmann, A. M.; Qiao, L.; Schreckenberger, C.; Gynecologic oncology
- Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Street, D.; Kaufmann, A. M.; Vaughan, A.; Fisher, S. G.; Hunter, M.; Schreckenberger, C.; Potkul, R. K.; Gissmann, L.; Qiao, L.; Gynecologic oncology
- High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Stiff, P. J.; Bayer, R.; Kerger, C.; Potkul, R. K.; Malhotra, D.; Peace, D. J.; Smith, D.; Fisher, S. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Reply. Delgado, G.; Potkul, R. K.; Gynecologic oncology
- Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Erlich, E.; McCall, A. R.; Potkul, R. K.; Walter, S.; Vaughan, A.; Gynecologic oncology
- The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. McCall, A. R.; Olson, M. C.; Potkul, R. K.; Cancer
- Retroperitoneal radical hysterectomy. Delgado, G.; Potkul, R. K.; Dolan, J. R.; Gynecologic oncology
- Vulvar reconstruction using a mons pubis pedicle flap. Potkul, R. K.; Barnes, W. A.; Barter, J. F.; Delgado, G.; Spear, S. L.; Gynecologic oncology